FABIO MASTROSIMONE

Fabio Mastrosimone is a distinguished investor at 3B Future Health Ventures, also known as the Helsinn Investment Fund, a strategic venture capital fund dedicated to transforming the future of health. In his pivotal role, Fabio Mastrosimone is instrumental in identifying, evaluating, and nurturing early-stage and growth-stage companies that are pioneering advancements across the healthcare and life sciences landscape. His work directly contributes to the fund's mission of investing in innovative solutions that address significant unmet medical needs and improve patient outcomes globally.

At 3B Future Health Ventures, Fabio Mastrosimone's investment focus spans a broad spectrum of critical areas within the health sector. This includes cutting-edge therapeutics, particularly in oncology and rare diseases, where the potential for impact is profound. He also actively explores opportunities in digital health, medical devices, diagnostics, and other health technology innovations that promise to revolutionize patient care, streamline healthcare delivery, and enhance overall well-being. The fund, backed by the pharmaceutical expertise of the Helsinn Group, leverages deep industry knowledge to support its portfolio companies beyond just capital, offering strategic guidance and access to a vast network.

Fabio Mastrosimone's career background provides a robust foundation for his current role as an investor. Prior to joining 3B Future Health Ventures, he gained valuable experience within the broader Helsinn Group, specifically in Corporate Development & M&A. This experience equipped him with a keen understanding of strategic business growth, market analysis, and the complexities of the pharmaceutical industry. Earlier in his career, Fabio honed his analytical and financial acumen at Deloitte, working in Audit & Assurance. This diverse professional journey has endowed him with a comprehensive perspective on both financial rigor and strategic healthcare innovation, making him a highly effective and insightful investor.

While specific individual investments are often proprietary, Fabio Mastrosimone's work at 3B Future Health Ventures contributes to a portfolio of companies poised to make significant contributions to global health. The fund's strategy involves backing visionary entrepreneurs and scientific teams developing next-generation treatments and technologies. Through his diligent efforts, Fabio Mastrosimone helps drive the fund's commitment to fostering a healthier future by investing in the most promising innovations in biotech, pharma, and health tech. His dedication ensures that 3B Future Health Ventures remains at the forefront of healthcare venture capital, supporting the breakthroughs that will define tomorrow's medicine.